Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Update on myasthenia gravis.

B R Thanvi1, T C N Lo

  • 1Department of Integrated Medicine, Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust, Leicester, UK. bthanvi@hotmail.com

Postgraduate Medical Journal
|December 8, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Advances in spontaneous intracerebral haemorrhage.

International journal of clinical practice·2012
Same author

Cannabis and stroke: is there a link?

Postgraduate medical journal·2009
Same author

Haemorrhagic transformation in acute ischaemic stroke following thrombolysis therapy: classification, pathogenesis and risk factors.

Postgraduate medical journal·2008
Same author

Psychosis in Parkinson's disease.

Postgraduate medical journal·2005
Same author

Long term motor complications of levodopa: clinical features, mechanisms, and management strategies.

Postgraduate medical journal·2004
Same author

Value of routine duodenal biopsy in diagnosing coeliac disease in patients with iron deficiency anaemia.

Postgraduate medical journal·2004

Myasthenia gravis is an autoimmune neuromuscular junction disorder. While diagnosis and treatment are highly successful, gaps remain in understanding its origins and achieving a cure.

Area of Science:

  • Neurology
  • Immunology
  • Molecular Biology

Background:

  • Myasthenia gravis is an autoimmune disorder targeting nicotinic acetylcholine receptors at the neuromuscular junction.
  • It causes muscle weakness and fatigability, with a bimodal incidence peaking in the third and sixth decades.
  • The condition may be underdiagnosed in the elderly, despite significant advances in understanding its pathogenesis.

Purpose of the Study:

  • To outline the current knowledge of myasthenia gravis.
  • To highlight advancements in pathogenesis, immunology, and molecular biology.
  • To identify remaining gaps in understanding disease origin, chronicity, and cure.

Main Methods:

  • Review of current scientific literature on myasthenia gravis.
  • Synthesis of information on diagnosis, pathogenesis, and treatment.

Related Experiment Videos

  • Identification of areas requiring further research.

    • Main Results:

    • Diagnosis of myasthenia gravis is reliably established with current tests.
    • Modern treatments are highly successful, with near-zero mortality.
    • Significant progress has been made in understanding the disease's molecular and immunological aspects.

    Conclusions:

    • While diagnosis and treatment of myasthenia gravis have advanced significantly, fundamental questions about its origin and potential cure persist.
    • Further research is needed to address the gaps in understanding the factors contributing to chronic disease.
    • The article provides a comprehensive overview of the current state of knowledge on myasthenia gravis.